Roche Diagnostics https://www.roche.com launched their NAVIFY Tumor Board solution, a decision support software that optimizes decision-making for cancer patient case reviews plus provides decision support to oncology care teams.
This new software solution fundamentally changes the way oncology care teams prepare for, conduct, and document clinical treatment decisions for cancer patients. The software solution is built on a secure cloud platform that is HIPAA compliant and is available in the U.S, UK, Germany, Spain, Sweden, and Switzerland.
Today, tumor board coordination is labor intensive and time consuming for healthcare providers. Information has to be made available through patient EMRs, plus information on biomarkers, tumors, along with radiology images, microscope slide images, and pathology reports have to be collected and organized manually.
The new NAVIFY Tumor Board solution streamlines, standardizes workflows by aggregating relevant patient data from disparate sources into a comprehensive dashboard. This collection of information facilitates efficient team collaboration, reduces errors, and gives the care team more time to evaluate potential treatment options.
In the near future, the portfolio will rapidly evolve to include additional decision support applications and workflow products that will help address challenges faced by healthcare providers as well as research and development applications.